| |
|
|
| Name: |
Affinity Asset Advisors LLC |
| City: |
Bridgehampton |
| State: |
NY |
| Zip: |
11932 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
22 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
CERE |
Cerevel Therapeutics Holdin... |
2 |
- |
$42.19 |
$31,800,000 |
750,000 |
6.71% |
16,845,000 |
64,939 |
0.48 |
N/A |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
4 |
- |
$205.25 |
$23,138,000 |
100,000 |
4.88% |
10,725,000 |
15,000 |
0.603 |
Diagnostic Substances |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
5 |
- |
$0.00 |
$21,188,000 |
460,000 |
4.47% |
10,925,000 |
159,562 |
0.736 |
N/A |
|
|
LIAN |
Lianbio |
8 |
- |
$0.00 |
$16,895,000 |
3,779,694 |
3.56% |
15,893,000 |
3,107,337 |
3.525 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
10 |
- |
$39.92 |
$15,864,000 |
400,000 |
3.35% |
11,736,000 |
250,000 |
0.764 |
Diagnostic Substances |
|
|
IMVT |
Immunovant Inc |
12 |
- |
$0.00 |
$14,535,000 |
345,000 |
3.07% |
3,018,000 |
45,000 |
0.396 |
N/A |
|
|
NUVL |
Nuvalent, Inc. |
14 |
- |
$0.00 |
$12,878,000 |
175,000 |
2.72% |
10,579,000 |
125,000 |
0.307 |
N/A |
|
|
ATXS |
Astria Therapeutics, Inc |
15 |
- |
$9.73 |
$11,262,000 |
1,466,465 |
2.38% |
3,800,000 |
466,165 |
5.912 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
16 |
- |
$0.00 |
$11,209,000 |
563,824 |
2.36% |
5,205,000 |
195,495 |
0.769 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
17 |
- |
$0.60 |
$11,138,000 |
517,554 |
2.35% |
8,170,000 |
275,257 |
0.846 |
N/A |
|
|
ALKS |
Alkermes Plc |
19 |
- |
$24.05 |
$9,886,000 |
356,384 |
2.09% |
7,085,000 |
256,384 |
0.217 |
Drug Delivery |
|
|
INZY |
Inozyme Pharma, Inc. |
20 |
- |
$0.00 |
$8,034,000 |
1,885,802 |
1.7% |
2,239,000 |
505,950 |
3.053 |
N/A |
|
|
NRIX |
Nurix Therapeutics, Inc. |
21 |
- |
$0.00 |
$7,122,000 |
690,112 |
1.5% |
5,157,000 |
440,112 |
1.467 |
N/A |
|
|
MRTX |
Mirati Therapeutics, Inc. |
24 |
- |
$58.70 |
$5,878,000 |
100,049 |
1.24% |
3,246,000 |
39,623 |
0.149 |
Biotechnology |
|
|
ROIV |
Roivant Sciences Ltd. |
25 |
- |
$11.13 |
$5,615,000 |
500,000 |
1.18% |
3,863,000 |
350,000 |
0.072 |
N/A |
|
|
APLS |
Apellis Pharmaceuticals Inc |
29 |
- |
$41.99 |
$4,490,000 |
75,000 |
0.95% |
2,968,000 |
35,000 |
0.066 |
N/A |
|
|
MLTX |
Multisys Language Solutions... |
30 |
- |
$0.00 |
$4,287,000 |
70,988 |
0.9% |
1,437,000 |
20,988 |
0.173 |
N/A |
|
|
DVAX |
Dynavax Technologies Corp |
31 |
- |
$10.73 |
$4,194,000 |
300,000 |
0.88% |
1,240,000 |
100,000 |
0.223 |
Drug Manufacturers - ... |
|
|
AXSM |
Axsome Therapeutics, Inc. |
33 |
- |
$72.50 |
$3,980,000 |
50,000 |
0.84% |
3,980,000 |
50,000 |
0.134 |
N/A |
|
|
SWTX |
Springworks Therapeutics, Inc. |
34 |
- |
$0.00 |
$3,650,000 |
100,000 |
0.77% |
2,689,000 |
58,419 |
0.144 |
N/A |
|
|
BBIO |
Bridgebio Pharma, Inc. |
36 |
- |
$29.10 |
$3,230,000 |
80,000 |
0.68% |
2,439,000 |
50,000 |
0.05 |
N/A |
|
|
MIRM |
Mirum Pharmaceuticals, Inc. |
51 |
- |
$0.00 |
$1,476,000 |
50,000 |
0.31% |
528,000 |
20,000 |
0.136 |
N/A |
|
